Related Experiment Videos
Maternal factors in congenital limb-reduction defects.
Teratology
|August 1, 1985
Summary
Maternal health factors like lower birth weight and complications such as diabetes mellitus are associated with limb-reduction defects in newborns. Thyroid medication use during pregnancy also emerged as a significant risk factor.
Area of Science:
- Pediatric epidemiology
- Congenital anomalies research
- Maternal health studies
Background:
- Limb-reduction defects are a significant concern in pediatric health.
- Understanding maternal risk factors is crucial for prevention strategies.
- Previous studies have suggested various potential contributing factors.
Purpose of the Study:
- To investigate maternal characteristics associated with limb-reduction defects.
- To identify specific pregnancy complications and medication use as potential risk factors.
- To compare risk factors across different subgroups of limb-reduction defects.
Main Methods:
- Case-control studies utilizing birth records and maternal interviews.
- Analysis of data from live births in Upstate New York (1970-1981 and 1968-1974).
- Comparison of cases with limb defects against healthy controls.
Main Results:
- Lower mean birth weight and gestation length were observed in infants with limb defects.
- Increased reporting of abnormal vaginal bleeding and diabetes mellitus in mothers of affected infants.
- Maternal thyroid medication use identified as a significant risk factor in an interview-based study.
Conclusions:
- Maternal health status and specific pregnancy complications are linked to limb-reduction defects.
- Thyroid medication use during pregnancy warrants further investigation as a potential teratogen.
- Subgroup analysis indicates that multiple defects are associated with the most severe outcomes regarding birth weight and gestation.